(i)
industrial purposes including the manufacture or compounding of consumer items or
products, which have no pharmacological action or medicinal purpose; and
(ii)
analytical laboratory purposes.
(b)
All substances referred to in this Schedule include the following:
(i)
The salts and esters of such substances, where the existence of such salts and esters
is possible; and
(ii)
all preparations and mixtures of such substances where such preparations and
mixtures are not expressly excluded.
(c)
In terms of Section 22A (5) ( f ) of the Act, a practitioner, nurse or a person registered
under the Health Professions Act, 1974, other than a medical practitioner or dentist, may prescribe and
supply to patients under their care, the Schedule 4 substances and medicines provided for in the
Annexures, only within their scope of practice and subject to the conditions determined by the Medicines
Control Council. The conditions and the Annexures will be published in the Gazette.
Abacavir.
Acarbose.
Acetarsone diethylamine salt, where intended for injection.
Acyclovir, except where intended for application to the lips in the early treatment of recurrent Herpes
simplex virus infections. (S1)
Adenosine.
Adrenaline, where intended for injection. (S2, S3)
Albendazole, except where intended and registered as an anthelmintic in terms of the provisions of the
Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947.
Alcuronium.
Aldesleukin.
Alfuzosin.
Alisapride.
Almitrine.
Alosetron.
Alphacalcidol, except when registered in terms of the provisions of the Fertilizers, Farm Feeds,
Agricultural Remedies and Stock Remedies Act, 1947.
Alphachymotrypsin, when intended for ophthalmic use.
Alprostadil.
Amantadine.
Amifostine.
Aminoglutethimide.
Aminopyrine (amidopyrine).
Amiodarone.
Amiphenazole.
Amprenavir.
Amrinone.
Amsacrine.
Anagrelide.
Anastrozole.
Anticoagulants, except preparations intended for application to the skin. (S1)
Antihemophilic factor.
Antimalarials, excluding chloroquine in combination with proguanil when intended specifically for malaria
prophylaxis. (S1)
Antimicrobial substances synthesised in nature or the laboratory, being substances used in the specific
treatment of infections, except the following when intended for topical application to the epidermis, nares
and external ear:
Bacitracin; (S1)
gramicidin; (S1)
griseofulvin; (S2)
mupirocin; (S2)
natamycin; (S2)
nystatin; (S1, S2)
polymyxin B; (S1)
tyrothricin; (S1)
and except where intended for use as germicides and antiseptics, and except nystatin oral drops (S1)
and except nystatin where intended for human vaginal use, specifically for the treatment of recurrent
vaginal candidiasis (S1), and except phenoxymethylpenicillin where intended for the prophylaxis of
rheumatic fever (S3) and except where intended for use as indicated below and registered in terms of
the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947:
Ampicillin, cloxacillin, dihydrostreptomycin, penethamate hydriodide and procaine benzylpenicillin; intramammary preparations thereof, containing tracer dye(s) and intended for the treatment of mastitis in
cattle;